ACLA Recommends Deregulatory Proposals to the Administration April 10, 2025Comments and Letters, Regulatory Issuesaclasuperadmin American Clinical Laboratory Assoc Deregulatory Recommendations to Trump Admin 4-10-2025Download
ACLA Responds to White House RFI on AI Action Plan March 15, 2025Comments and Lettersaclasuperadmin ACLA Response to RFI on AI 3-15-25 finalDownload
ACLA Comments on CMS MA Part D Proposed Rule January 28, 2025Comments and Lettersaclasuperadmin ACLA Comment Letter – MA Part D Proposed Rule (CMS-4208-P) 1-27-2025 (002)Download
ACLA Urges FDA To Adopt Greater Flexibility Predetermined Change Control Plans (PCCPs) November 1, 2024Comments and Lettersaclasuperadmin ACLA Comments on PCCP Draft Guidance 11.1.2024Download
ACLA Comments on CY 2025 PFS Proposed Rule September 9, 2024Comments and Lettersaclasuperadmin ACLA Comments on CY 2025 PFS Proposed RuleDownload
ACLA Response to Cures 2.0 RFI August 2, 2024Comments and Lettersaclasuperadmin ACLA-Response-to-Cures-RFI_080224_v2_FINALDownload
ACLA Statement to Ways & Means Committee on Innovation Field Hearing July 12, 2024Comments and Lettersaclasuperadmin Statement-of-ACLA_WM-Hearing-on-Medical-Innovation-7.12.24-FINALDownload
ACLA Weighs in on American Privacy Rights Act (APRA) June 25, 2024Comments and Lettersaclasuperadmin ACLA-Comments-on-American-Privacy-Rights-Act-6.25.24Download
ACLA Response to CMS RFI on Medicare Advantage Data May 29, 2024Comments and Lettersaclasuperadmin Download (PDF, 204KB)
ACLA Recommendations to Congress on Prior Authorization and Medical Documentation Reform April 5, 2024Reimbursement and Coverageaclasuperadmin Download (PDF, 74KB)
